Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis

BACKGROUND AND OBJECTIVES: To estimate the proportions of patients with relapsing-remitting multiple sclerosis who despite achieving the no evidence of disease activity-3 (NEDA-3) status in the first 2 treatment years experienced relapse-associated worsening (RAW) or progression independent from rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperini, Luca, Ruggieri, Serena, Haggiag, Shalom, Tortorella, Carla, Pozzilli, Carlo, Gasperini, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353667/
https://www.ncbi.nlm.nih.gov/pubmed/34373345
http://dx.doi.org/10.1212/NXI.0000000000001059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353667/
https://www.ncbi.nlm.nih.gov/pubmed/34373345
http://dx.doi.org/10.1212/NXI.0000000000001059

Ejemplares similares